Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)
- Citation:
- Blood Adv vol 3 (11) 1714-1721
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- Yes
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 8
- Parents:
- 2990
- Children:
- None
- Pharmas:
- Novartis, BMS, Bayer
- Grants:
- U10CA180821, U10CA180882, U10CA180833, U10CA180836, U10CA180850, U10CA180867
- Corr. Author:
- Authors:
- Jun Yin Betsy LaPlant Geoffrey L. Uy Guido Marcucci William Blum Richard A. Larson Richard M. Stone Sumithra J. Mandrekar
- Networks:
- CA043, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007
- Study
- Alliance-A151614
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-10201, CALGB-10503, CALGB-10603, CALGB-10801, CALGB-11001
- Phases:
- N/A, 2, 3
- Keywords:
- 20, 25, Clinical Trials and Observations